A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective

by Baker CL, Ding Y, Ferrufino CP, Kowal S, Tan J, Subedi P
Published 2018-07-01

Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies

by Ferrufino CP, Munakata J, Wei W, Proudfoot C, Kuznik A, Boklage SH, Chen C
Published 2018-11-01

Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies [Co...

by Ferrufino CP, Munakata J, Wei W, Proudfoot C, Kuznik A, Boklage SH, Chen C
Published 2019-01-01